Management of Xarelto for Back Injections

Introduction to Xarelto Management

The American Society of Regional Anesthesia and Pain Medicine recommends stopping Xarelto for 3 days prior to a back injection, as back injections involving neuraxial procedures are classified as very high bleeding risk procedures requiring complete drug clearance 1, 2, 3

Back injections involving epidural or spinal approaches are categorized as very high hemorrhagic risk procedures because spinal/epidural bleeding can cause permanent neurological damage, and surgical hemostasis cannot be performed safely in this anatomical location 1, 2, 4
Guidelines explicitly state that neuraxial anesthesia/puncture requires a longer interruption time of direct oral anticoagulants (DOAs) prior to the planned procedure—up to 5 days for rivaroxaban (Xarelto) in the absence of renal failure 1, 2

For patients with normal or mildly impaired renal function (CrCl >50 mL/min), stop Xarelto 3 days (72 hours) before the back injection, which corresponds to the last dose being taken on the morning 3 days prior to the procedure 5, 3
For patients with moderate renal impairment (CrCl 30-50 mL/min), extend the discontinuation period to 4-5 days due to slower drug clearance and prolonged half-life 1, 5, 2

Obtain a recent creatinine clearance measurement using the Cockcroft-Gault formula before determining the exact hold duration, as rivaroxaban has significant renal elimination (approximately 33% unchanged in urine) 1, 5, 3
Check for concomitant medications that may prolong rivaroxaban levels, including P-glycoprotein inhibitors (e.g., ketoconazole, erythromycin, ritonavir) or CYP3A4 inhibitors, which may require extending the hold period up to 5 days 1, 2, 3

Do not use preoperative heparin bridging (unfractionated heparin or low-molecular-weight heparin) when discontinuing Xarelto for this procedure 1, 2, 3

Resume Xarelto 48-72 hours after the back injection, provided adequate hemostasis has been established and there is no ongoing bleeding or surgical contraindication 1, 2, 3

Never perform neuraxial anesthesia or spinal puncture in patients with possible residual Xarelto concentration due to insufficient discontinuation time 1, 2, 3
This is the single most important pitfall to avoid, as inadequate drug clearance during neuraxial procedures can result in spinal hematoma with permanent neurological sequelae 1, 2